FERARI Study: Supplementation with Ferric Sodium EDTA in the Treatment of Anemia during Pregnancy

Select Content Type
Resources
Authored By
Shalina MedSpace
Authored On
Interests
Cardiology
Dermatology
Emergency Medicine
Endocrinology
ENT
Gastroenterology
Hematology
Immunology Allergy & Inflammation
Infectious Disease & Vaccines
Internal/Family Medicine
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopedic
Pain & Anesthesiology
Pediatric Medicine
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology & Nephrology
Speciality
Cardiology
Dentistry
Dermatology
Emergency Medicine
Endocrinology
ENT
Gastroenterology
Geriatrics
Hematology
Immunology Allergy & Inflammation
Infectious Disease & Vaccines
Internal/Family Medicine
Medical Genetics
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopedic
Pain & Anesthesiology
Pathology
Pediatric Medicine
Pharmacology
Psychiatry
Public Health
Pulmonology
Radiology
Rheumatology
Surgery
Urology & Nephrology
Thumbnail Image
Ferari study_thumbnail
Detail Image
Ferari study_detailed
Book Detail
Upload PDF
FERARI Study Supplementation with Ferric Sodium EDTA in the Treatment of Anemia during Pregnancy_2021.pdf (315.95 KB)
Actions
Download in App
Promotional Categories
Featured
Countries of release
Angola
Central African Republic (CAR)
Democratic Republic of the Congo (DRC)
Ghana
India
Kenya
Nigeria
UAE
Zambia
IS_Ebsco
false
Description

Explore the FERARI study conducted among 337 pregnant women receiving antenatal care between May and December 2020 in the Democratic Republic of Congo. Participants were given Hemoforce Plus Zinc® syrup (containing Ferric Sodium EDTA), and were found to have significantly improved hemoglobin levels in within three weeks, with minimal side effects and high tolerability, making it a promising alternative to conventional iron therapies for managing iron deficiency anemia in pregnancy.

Published Date